Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model
Authors:
- 9 September 2008
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 32 (11) , 1705-1711
Abstract
To establish that human adipocytes express functional glucose-dependent insulinotropic peptide (GIP) receptors and in particular the regulation of GIP receptor (GIPR) expression in the context of the dynamic process of adipocyte differentiation. A combination of semiquantitative real-time PCR and measurement of GIP-stimulated cAMP accumulation was used to establish the expression and functional coupling of GIPRs during in vitro differentiation of human Simpson–Golabi–Behmel syndrome (SGBS) preadipocytes. Semiquantitative real-time PCR revealed that GIPR expression was substantially increased by day 4 of differentiation, reaching a maximum around 6–8 days ( ∼ 200-fold increase above undifferentiated cells, n=2). We also analysed the expression of the adipocyte fatty acid binding protein (FABP4) to relate GIPR expression to a molecular differentiation marker of adipogenesis. FABP4 expression was barely detectable in undifferentiated cells. However, following exposure to adipogenic medium, FABP4 expression gradually increased, with a maximal expression level around 10 days ( ∼ 1 600 000-fold increase above undifferentiated cells, n=2). Thus, the increases in GIPR mRNA during adipogenesis occur earlier than FABP4, suggesting that it might represent a gene expressed early in terminal differentiation and thus plays a role in fat droplet formation. A unit of 1 μM GIP failed to raise intracellular cAMP levels above basal levels in undifferentiated cells (n=3). In stark contrast, the 9-day differentiated cells produced a robust concentration-dependent increase in cAMP accumulation following stimulation with GIP, with an EC50 value of 2.3 nM (n=3). The maximal response represented a 9–34-fold increase in cAMP accumulation above basal levels. This study demonstrates that GIPRs are expressed by human adipocytes, both GIPR mRNA and functional receptor expression being present in differentiated adipocytes but not in preadipocytes. Further investigation into the functional effects of GIP on differentiated SGBS cells could help towards understanding exactly how GIP regulates fat accumulation in human adipocytes.Keywords
This publication has 41 references indexed in Scilit:
- Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria dietsDiabetologia, 2007
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in AdipocytesJournal of Biological Chemistry, 2007
- Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretinDiabetologia, 2003
- Inhibition of gastric inhibitory polypeptide signaling prevents obesityNature Medicine, 2002
- Characterization of the Cellular and Metabolic Effects of a Novel Enzyme-Resistant Antagonist of Glucose-Dependent Insulinotropic PolypeptideBiochemical and Biophysical Research Communications, 2002
- GIF biology and fat metabolismLife Sciences, 1999
- Functional GIP Receptors Are Present on AdipocytesEndocrinology, 1998
- Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the ratRegulatory Peptides, 1983
- Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjectsDiabetes, 1978